Study design for restricted mean time analysis of recurrent events and death
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Study design for restricted mean time analysis of recurrent events and death
Authors
Keywords
-
Journal
BIOMETRICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-08-24
DOI
10.1111/biom.13923
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- On recurrent-event win ratio
- (2022) Lu Mao et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Power and Sample Size Calculations for the Restricted Mean Time Analysis of Prioritized Composite Endpoints
- (2022) Lu Mao Statistics in Biopharmaceutical Research
- A sensitivity analysis approach for the causal hazard ratio in randomized and observational studies
- (2022) Rachel Axelrod et al. BIOMETRICS
- An alternative formulation of Coxian phase‐type distributions with covariates: Application to emergency department length of stay
- (2021) Jean Rizk et al. STATISTICS IN MEDICINE
- Estimands for recurrent event endpoints in the presence of a terminal event
- (2021) Heinz Schmidli et al. Statistics in Biopharmaceutical Research
- Statistical models for composite endpoints of death and non-fatal events: a review
- (2021) Lu Mao et al. Statistics in Biopharmaceutical Research
- Sample size calculation for recurrent event data with additive rates models
- (2021) Liang Zhu et al. PHARMACEUTICAL STATISTICS
- Methodological challenges in the analysis of recurrent events for randomised controlled trials with application to cardiovascular events in LEADER
- (2021) Julie Kjærulff Furberg et al. PHARMACEUTICAL STATISTICS
- On restricted mean time in favor of treatment
- (2021) Lu Mao BIOMETRICS
- On the empirical choice of the time window for restricted mean survival time
- (2020) Lu Tian et al. BIOMETRICS
- Subtleties in the interpretation of hazard contrasts
- (2020) Torben Martinussen et al. LIFETIME DATA ANALYSIS
- Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease
- (2020) Orly Vardeny et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adjusting win statistics for dependent censoring
- (2020) Gaohong Dong et al. PHARMACEUTICAL STATISTICS
- Sample size calculation for the Andersen‐Gill model comparing rates of recurrent events
- (2019) Yongqiang Tang et al. STATISTICS IN MEDICINE
- Sample size and power for the weighted log‐rank test and Kaplan‐Meier based tests with allowance for nonproportional hazards
- (2019) Godwin Yung et al. BIOMETRICS
- Estimands and Their Role in Clinical Trials
- (2017) Mouna Akacha et al. Statistics in Biopharmaceutical Research
- Semiparametric regression for the weighted composite endpoint of recurrent and terminal events
- (2015) Lu Mao et al. BIOSTATISTICS
- Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer
- (2015) J Péron et al. BRITISH JOURNAL OF CANCER
- Does Cox analysis of a randomized survival study yield a causal treatment effect?
- (2015) Odd O. Aalen et al. LIFETIME DATA ANALYSIS
- Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
- (2014) Jennifer K. Rogers et al. EUROPEAN JOURNAL OF HEART FAILURE
- Sample Size Determination in Shared Frailty Models for Multivariate Time-to-Event Data
- (2014) Liddy M. Chen et al. Journal of Biopharmaceutical Statistics
- Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials?
- (2012) S. D. Anker et al. EUROPEAN HEART JOURNAL
- Sample size calculation for recurrent events data in one-arm studies
- (2012) Paola Rebora et al. PHARMACEUTICAL STATISTICS
- The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
- (2011) S. J. Pocock et al. EUROPEAN HEART JOURNAL
- The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt
- (2011) Patrick Royston et al. STATISTICS IN MEDICINE
- Estimating treatment effects on the marginal recurrent event mean in the presence of a terminating event
- (2010) Douglas E. Schaubel et al. LIFETIME DATA ANALYSIS
- Generalized pairwise comparisons of prioritized outcomes in the two-sample problem
- (2010) Marc Buyse STATISTICS IN MEDICINE
- The Hazards of Hazard Ratios
- (2009) Miguel A. Hernán EPIDEMIOLOGY
- Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure
- (2009) Christopher M. O’Connor et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Semiparametric Transformation Models with Random Effects for Joint Analysis of Recurrent and Terminal Events
- (2008) Donglin Zeng et al. BIOMETRICS
- Sample size formula for randomized controlled trials with counts of recurrent events
- (2008) Toshiro Tango STATISTICS & PROBABILITY LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More